Tag: Omicron
Re-emergence of Covid-19 cases deeply concerning: Expert
Dr Sohini Sengupta, the Medical Laboratory Director at Redcliffe Labs, provides valuable insights into managing the situation
India’s first mRNA based Omicron-specific booster vaccine from Gennova gets DCGI...
The Omicron specific mRNA vaccine will be available under the name - GEMCOVAC®-OM. The intradermal vaccine is stable at 2-8 °C and is administered using a needle-free device
Genetic recombination made Omicron more infectious
The Indian researchers have found that recombination events had escalated during the Omicron wave, which made the virus more immune-evasive and infectious.
Vaccines with efficacy against Omicron variants will gain competitive advantage in...
According to GlobalData’s Pharma Intelligence Center, there are currently 19 COVID-19 vaccines in clinical development in China, with only 3 candidates in Phase III trials
Moderna seeks US-FDA approval for emergency use of BA.4/BA.5 Omicron booster
Subject to the regulatory approval, Moderna is ready to ship bivalent booster mRNA-1273.222 in September
The Gamaleya Center develops Delta & Omicron-adapted Sputnik V vaccine
The Delta and Omicron-adapted version of Sputnik V is the most promising version of the vaccine specifically adapted to new variants as compared to those tailored against the combination of the original strain and Omicron variant
ICAR launches Covid-19 vaccine for animals
The Ancovax Vaccine on Equines, an inactivated SARS-CoV-2 Delta (COVID-19) vaccine for animals neutralizes both Delta and Omicron variants
Delta variant might return back, warn Israeli researchers
While Delta wiped out the variants that preceded it, Omicron has not eliminated Delta
Mathematical model to predict COVID-19 vaccine efficacy
The researchers began by analysing over 80 different neutralising antibodies reported to be generated after vaccination against the surface spike protein of SARS-CoV-2, the virus that causes COVID-19
Delta & Omicron may both co-circulate: Experts
While Delta has two mutations on the receptor-binding domain of the spike protein, Omicron has 15. This has resulted in evasion from antibody binding, necessary for protection.





























































